DMRA
Price
$22.87
Change
-$1.02 (-4.27%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
1.47B
43 days until earnings call
Intraday BUY SELL Signals
GNTA
Price
$1.86
Change
-$0.06 (-3.12%)
Updated
Jun 23, 04:53 PM (EDT)
Capitalization
45.53M
Intraday BUY SELL Signals
Interact to see
Advertisement

DMRA vs GNTA

DMRA vs GNTA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
DMRA vs. GNTA commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DMRA is a Hold and GNTA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (DMRA: $23.84 vs. GNTA: $1.93)
Brand notoriety: DMRA and GNTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DMRA: 144% vs. GNTA: 72%
Market capitalization -- DMRA: $1.47B vs. GNTA: $45.53M
DMRA [@Biotechnology] is valued at $1.47B. GNTA’s [@Biotechnology] market capitalization is $45.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DMRA’s FA Score shows that 1 FA rating(s) are green whileGNTA’s FA Score has 1 green FA rating(s).

  • DMRA’s FA Score: 1 green, 4 red.
  • GNTA’s FA Score: 1 green, 4 red.
According to our system of comparison, DMRA is a better buy in the long-term than GNTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DMRA’s TA Score shows that 5 TA indicator(s) are bullish while GNTA’s TA Score has 3 bullish TA indicator(s).

  • DMRA’s TA Score: 5 bullish, 4 bearish.
  • GNTA’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, DMRA is a better buy in the short-term than GNTA.

Price Growth

DMRA (@Biotechnology) experienced а +18.78% price change this week, while GNTA (@Biotechnology) price change was +7.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.89%. For the same industry, the average monthly price growth was +2.09%, and the average quarterly price growth was +1952.22%.

Reported Earning Dates

DMRA is expected to report earnings on Aug 05, 2026.

Industries' Descriptions

@Biotechnology (+5.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DMRA($1.47B) has a higher market cap than GNTA($45.5M). GNTA YTD gains are higher at: 29.530 vs. DMRA (3.607).
DMRAGNTADMRA / GNTA
Capitalization1.47B45.5M3,224%
EBITDA-238.99MN/A-
Gain YTD3.60729.53012%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash533MN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
DMRAGNTA
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 7 days ago
85%
Bullish Trend 13 days ago
82%
Declines
ODDS (%)
Bearish Trend 9 days ago
87%
Bearish Trend 6 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
DMRA
Daily Signal:
Gain/Loss:
GNTA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PSCI180.930.98
+0.55%
Invesco S&P SmallCap Industrials ETF
CAIE27.17-0.02
-0.07%
Calamos US Eq Autocallable Income ETF
TDAX25.87-0.12
-0.46%
TDAQ Lift ETF
XLSR64.95-0.59
-0.90%
State Street® US Sector Rotation ETF
MUSQ24.83-0.59
-2.32%
MUSQ Global Music Industry Idx ETF